Regenerative Medicine Product – to facilitate healing and help regenerating damaged tissues - such as:
Therapeutic Delivery Technologies –aiming at effectively delivering biotherapeutic agents
Several limitations exist for oral delivery of promising drugs, such as their instability in the digestive tract and their inability to be absorbed in an active form or their short-half life in the blood.
Consequently, many of these drugs require administration through frequent injections, limiting their clinical value. BioSyntech responds to the need for new approaches to deliver such therapeutics to their targeted site of action.
Therapies which can be delivered through BST-Gel® injections include water-soluble and –insoluble molecules, peptides, proteins and growth factors, as well as genes and cells (e.g. stem cells, chondrocytes, fibroblasts.).